Rochester Clinical Research is enrolling adults ages 18 and older for a study looking at a new treatment for people with type 2 diabetes, high blood pressure, and heart disease.
This study is enrolling at both Rochester & Buffalo locations.
Rochester Clinical Research is enrolling adults ages 18 and older for a study looking at a new treatment for people with type 2 diabetes, high blood pressure, and heart disease.
This study is enrolling at both Rochester & Buffalo locations.
The purpose of this study is to see if adding an investigational medicine to a commonly used diabetes medication may help lower the risk of serious heart problems, such as heart failure or heart-related death. Researchers will also look at how the treatment may affect blood pressure and kidney health.
This study will include regular health check-ins, lab tests, and study visits to help monitor your safety and how well the treatment is working over time.
You May Qualify if you are:
Other qualifications apply during screening.
Adults 18 to 80 years of age may qualify for a study evaluating an investigational treatment for irritable bowel syndrome […]
Are you 50 or older and in good general health? If you’ve had a pneumonia shot in the past (like Prevnar® or Pneumovax®), you […]
High blood pressure (hypertension) occurs when the force of blood against artery walls is consistently too high. Over time, this […]
Researchers are studying a new investigational medication, CRB-913, which works on pathways involved in appetite and metabolism. This study aims to […]
Influenza (flu) is a contagious respiratory illness that can lead to serious complications, especially in older adults and individuals with […]
We are currently enrolling a weight loss study evaluating the safety, tolerability and effectiveness of a GLP-1 and GIP medication. If […]